# Ondansetron

## Supren inj 8mg/4mL

| TAH Drug Code      | [ISUP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ISUP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention or treatment of nausea and vomiting caused by surgery, chemotherapy or radiation therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Postoperative Nausea and Vomiting (PONV): Adults: (1) Prevention: Administer a single 4 mg dose via IM or slow IV injection (over at least 30 seconds) at the induction of anesthesia. (2) Treatment: A single 4 mg dose is recommended, administered IM or slow IV injection (over at least 30 seconds). If necessary, the dose can be increased to 8 mg. Children and Adolescents (1 month to 17 years): For prevention or treatment of PONV in children undergoing surgery with general anesthesia: Administer via slow IV injection (over at least 30 seconds) before, during, or after anesthesia induction, or post-surgery, at a dose of 0.1 mg/kg, up to a maximum of 4 mg. Clinical trials for ondansetron use in PONV treatment in children under 2 years have not been conducted. Chemotherapy or Radiotherapy-Induced Nausea and Vomiting (CINV and RINV): Adults: (1) Emetogenic Chemotherapy and Radiotherapy: Administer 8 mg IV slowly or IM injection before treatment. Follow with oral administration after 24 hours to prevent delayed or prolonged vomiting. (2) Highly Emetogenic Chemotherapy: Administer an 8 mg slow IV or IM injection before chemotherapy. For doses over 8 mg (up to 16 mg), dilute in 50-100 mL of normal saline or compatible solution and infuse over no less than 15 minutes. Do not exceed a single dose of 16 mg due to dose-dependent QT prolongation. Alternatively, use slow IV or IM injection of 8 mg ondansetron prior to chemotherapy, followed by two 8 mg doses 2-4 hours apart, or continuous infusion at 1 mg/hour up to 24 hours. Pre-treatment with a 20 mg IV dose of dexamethasone sodium phosphate can enhance ondansetron's antiemetic effect. Use oral or rectal treatment to prevent delayed vomiting after 24 hours. Children Over 6 Months and Adolescents: (1) Dosing based on Body Surface Area (BSA): Administer 5 mg/m2 IV prior to chemotherapy (max 8 mg), infusing over no less than 15 minutes. Begin oral dosing 12 hours later for up to 5 days. Do not exceed adult doses. - BSA Dosing Table (6 months to 17 years):** - **BSA < 0.6 m2:** Day 1: 5 mg/m2 IV + 2 mg syrup after 12 hours. Days 2-6: 2 mg syrup q12h. - **BSA ? 0.6 m2:** 5 mg/m2 IV + 4 mg syrup or tablet after 12 hours. Days 2-6: 4 mg syrup or tablet q12h. (2) Dosing based on Weight: Administer 0.15 mg/kg IV prior to chemotherapy (max 8 mg). On Day 1, additional two doses can be given 4 hours apart, infusing over no less than 15 minutes. Begin oral dosing 12 hours later for up to 5 days. Do not exceed adult doses. - **Weight Dosing Table (6 months to 17 years):** - **? 10 kg:** Day 1: Up to 3 doses of 0.15 mg/kg, every 4 hours. Days 2-6: 2 mg syrup q12h. - **> 10 kg:** Day 1: Up to 3 doses of 0.15 mg/kg, every 4 hours. Days 2-6: 4 mg syrup or tablet q12h. Elderly: For patients 61 and older, all IV doses should be diluted and infused over more than 15 minutes. If further doses are needed, allow at least 4 hours between doses. For ages 61-74, initial ondansetron dose is 8 or 16 mg, infused over more than 15 minutes, with additional 8 mg doses. For ages 75 and older, do not exceed an 8 mg initial dose, infused over more than 15 minutes, followed by two additional 8 mg infusions, at least 4 hours apart. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to ondansetron or any component of the product. Concomitant use of apomorphine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common: Rash (4%), Diarrhea (3.3%), Loss of appetite, Nausea (8-13.4%), Sensitive dentin, Sore gums, Vomiting (8.1%), Myalgia (6.4%), Bacterial vaginosis (3.3%). Serious: Drug reaction with eosinophilia and systemic symptoms, Erythema multiforme, Photosensitivity, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Clostridium difficile diarrhea, Hepatotoxicity (Rare), Anaphylaxis, Superinfection, Arrest of bone development AND/OR growth, Pseudotumor cerebri.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Human Data Suggest Risk in 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ondansetron-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

